Accrual and Recruitment Practices at Clinical and Translational Science Award (CTSA) Institutions: A Call for Expectations, Expertise, and Evaluation by Kost, Rhonda G. et al.
Accrual and Recruitment Practices at Clinical and Translational
Science Award (CTSA) Institutions: A Call for Expectations,
Expertise, and Evaluation
Rhonda G. Kost, MD, Sabrena Mervin-Blake, MSCR, Rose Hallarn, Charles Rathmann, H.
Robert Kolb, RN, Cheryl Dennison Himmelfarb, RN, ANP, PhD, Toni D’Agostino, MA, Eric
P. Rubinstein, JD, MPH, Ann M. Dozier, RN, PhD, and Kathryn G. Schuff, MD, MCR
Abstract
Purpose—To respond to increased public and programmatic demand to address underenrollment
of clinical translational research studies, the authors examine participant recruitment practices at
Clinical and Translational Science Award sites (CTSAs) and make recommendations for
performance metrics and accountability.
Method—The CTSA Recruitment and Retention taskforce developed and, in 2010, invited
representatives at 46 CTSAs to complete an online 48-question survey querying CTSA accrual
and recruitment outcomes, practices, evaluation methods, policies, and perceived gaps in related
knowledge/practice. Descriptive statistical and thematic analyses were conducted.
Results—Forty-six respondents representing 44 CTSAs completed the survey. Recruitment
conducted by study teams was the most common practice reported (78–91%, by study type); 39%
reported their institution offered recruitment services to investigators. Respondents valued study
feasibility assessment as a successful practice (39%); their desired additional resources included
feasibility assessments (49%) and participant registries (44%). None reported their institution
systematically required justification of feasibility; some indicated relevant information was
considered prior to IRB review (30%) or contract approval (22%). All respondents’ IRBs tracked
study progress, but only 10% of respondents could report outcome data for timely accrual. Few
reported written policies addressing poor accrual or provided data to support recruitment practice
effectiveness.
Conclusions—Many CTSAs lack the necessary framework to support study accrual.
Recommendations to enhance accrual include articulating institutional expectations and policy for
routine recruitment planning; providing recruitment expertise to inform feasibility assessment and
recruitment planning; and developing interdepartmental coordination and integrated informatics
infrastructure to drive the conduct, evaluation, and improvement of recruitment practices.
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Poor participant accrual into clinical trials at academic health centers (AHCs) in the United
States incurs financial costs to institutions, industry, and taxpayers, puts participants at risk,
delays scientific progress, and impedes medical discovery.1 The pervasive problem of
underenrollment in both clinical trials and investigator-initiated protocols is well recognized,
but there are few published data describing accrual at Clinical and Translational Science
Award (CTSA) sites or across the national CTSA consortium. Programmatic demand for
performance metrics and accountability among CTSA sites (CTSAs) has brought increased
scrutiny to institutional performance,1,2 yet there are currently no metrics or benchmarks
specific to accrual. A recent assessment of the costs of underenrollment of clinical trials at
one AHC estimated the direct losses to exceed $1 million annually.3 Including indirect costs
and investigator-initiated studies would substantially increase this figure, and the
opportunity costs to patients are incalculable. Thus, in 2009, the CTSA Recruitment and
Retention RR taskforce, a subcommittee of the national CTSA Regulatory Knowledge and
Support Key Function Committee (RKS KFC), was convened to assess current policies and
practices at CTSAs and to make recommendations to enhance recruitment and accrual
efforts.
For decades, industry has used centralized professional recruitment services--incorporating
recruitment expertise, economies of scale, and data-driven marketing approaches--to
optimize recruitment in commercially managed trials.4 However, at academic research
institutions, recruitment traditionally has been left in the hands of individual investigators,
who may have neither the resources nor the expertise to effectively execute accrual. RR
taskforce members hypothesized that the lack of integration of data, policy, and practice
related to recruitment and retention, and the scarcity of data in support of effective
recruitment and retention practices, were impeding efforts to build infrastructure at their
CTSAs to support successful accrual. To determine whether CTSAs have adequate policies,
infrastructure, and processes in place to measure accrual outcomes, to address
underenrollment, and to effectively improve recruitment/accrual outcomes for investigators,
the RR taskforce in 2010 fielded a CTSA consortium-wide survey focused on recruitment
and retention practices. Here, we describe the results of the survey and provide
recommendations for improving accrual at CTSAs.
Method
The 15-member RR taskforce was convened by the chair of the RKS KFC in July 2009. All
of this study’s authors were taskforce members.
Definition and scope of terms
The evaluation of recruitment or accrual outcomes is complicated by the absence of
common definitions of scope and practice. Within the working definition we developed for
the RR taskforce survey, the scope of “recruitment” encompasses a broad and
interdisciplinary set of activities conducted across the protocol’s life span, leading up to and
culminating in complete study enrollment (i.e., “accrual”). It extends beyond creating
advertisements or prescreening volunteers. Recruitment activities start with refinement of
the protocol design to balance burdens and benefits to participants5 and to include (1)
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assessment of feasibility as judged by incorporation of data concerning a broad set of factors
that potentially impact the target population’s availability or willingness to participate, and
(2) assessment of the availability of resources to effect recruitment. Some of the variables
that affect feasibility include the restrictiveness of eligibility criteria; competing forces that
affect the availability of target populations4; the time, effort, resources, and availability of
the research team; the availability of staff with recruitment expertise for call management
and prescreening; the resources afforded the recruiter; and the availability of infrastructure,
tools, and data to rationally optimize recruitment activities as they are conducted.6
Feasibility is ultimately an assessment of the likelihood of attaining timely accrual. Our
working definition for the outcome of “accrual” is the completion of enrollment of the
projected target number of evaluable participants within the projected time frame. This more
expansive definition of recruitment-- as a multi-step process for which effectiveness is
measured against the final outcome of study accrual-- incorporates elements of psychology,
customer service, marketing, efficiency, and performance improvement, and aligns with
both successful commercial recruitment practices and the CTSA goals of accelerating
translational science.
Survey development
Employing a broad and interdisciplinary definition of recruitment to capture the full scope of
activities contributing to participant recruitment and accrual, the RR taskforce developed a
48-question survey to examine recruitment practices, infrastructure, and evaluation at
CTSAs. (For the final survey, see Supplemental Digital Appendix 1). Most questions
included both fixed-answer responses and comments fields. One of the authors (R.K.)
created the initial draft, which was revised iteratively by the taskforce members. The draft
survey instrument was pilot-tested for face and content validity by taskforce members and
colleagues at their institutions and then refined based on those findings. The final survey
was endorsed by the RKS KFC prior to fielding. The survey was submitted to the
Rockefeller University Institutional Review Board (IRB) and was determined to be exempt
from IRB review.
Survey design
The survey was specifically designed to assess: (1) the outcome of accrual, defined as the
fraction of studies at the responding CTSA that attained complete study enrollment within 6
months of the projected timeline; (2) utilization and perceived success of common
recruitment and retention practices; (3) availability of institutional resources and
infrastructure to support recruitment; (4) evaluation methods for recruitment and retention
practices; (5) institutional policy relevant to study accrual; and (6) perceived gaps in
knowledge related to recruitment and retention practices. Many survey questions
distinguished between studies that were sponsored (i.e., decision-making authority lies with
industry/pharmaceutical company or other outside collaborators and not with the principal
investigator [PI]), nonsponsored (i.e., the main decision-making authority lies with the PI),
or at a dedicated center (e.g., concentrated in a cancer center, vaccine center, HIV/AIDS
center).
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A particular focus of the survey was whether study feasibility assessment and recruitment
planning were conducted in advance of study approval or initiation. Fulfilling these
functions can encompass a variety of activities. The survey asked about methods used for
determination of enrollment targets and timelines, methods used for any feasibility
assessments related to targets and timelines, and provision of any relevant institutional
resources to investigators to support assessments of feasibility. The survey also asked
whether the IRB or contract office requires demonstration of feasibility or adequate
recruitment budget prior to IRB or contract review, and whether the IRB requires a target
date for meeting the accrual target or has any processes in place to track or referee the
submission of studies competing for the same patient population. Free-text space was
provided for respondents to describe applicable requirements.
The survey also asked about the availability and administration of participant/patient
registries and the ability to track participant enrollment outcomes--whether tracking is in
place, whether the tracking enables assessment of the time elapsed from approval to the first
enrollment, and whether studies meet enrollment targets within a specified time frame.
Other survey items asked specifically whether remedies are suggested or assistance is
provided to investigators for underaccruing studies, and whether penalties are applied
through the contracts office or the IRB to investigators who persistently conduct
underaccruing studies. In addition, the survey asked how many studies over the prior 3 years
did not fully accrue within 6 months of the stated target date and whether a written policy is
in place to close studies for nonaccrual.
At the time of the survey in 2010, there were no CTSA consensus standards, definitions, or
metrics related to measures of study accrual or outcomes of recruitment activities.7 To
collect information about accrual outcome assessment, the survey asked directly about any
evaluation methods used and the source of information for reports of attaining accrual
targets or timeliness (e.g., data/source, experience, opinion). For any recruitment practices
described, the survey explicitly asked respondents to describe the evaluation methods used
to assess the value of those practices.
Survey fielding
The survey was fielded via an on-line platform (SurveyMonkey, www.surveymonkey.com)
in March–April 2010. The survey was deployed through the RKS KFC representatives
associated with each of the 46 then-funded CTSAs. To encourage accurate and complete
responses, the instructions indicated that respondents should collaborate as needed with
institutional colleagues to complete the survey. Printable worksheet copies were provided to
allow respondents to compile input from multiple sources before submitting their final
response online. The RKS KFC representative submitted the final online survey response for
each institution. Nonresponders were contacted once to encourage response.
Analysis
Survey responses were analyzed using descriptive statistics for fixed responses. Free-text
comments were analyzed for face content and coded with simple descriptive terms, using the
respondents’ own words when appropriate and compiling like terms (e.g., registry +
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database, recruitment core + centralized services + consultation service, successful practices
+ proven practices, measures of success + metrics). The initial coding was conducted by one
author (R.K.); that coding was reviewed by the convened RR taskforce during data analysis
conference calls. When a given respondent provided the same information by both fixed
response and free-text response for the same question, only the fixed response was included
in tallies. Comments containing more than one theme were coded for all their themes.
Results
Forty-six individuals representing 44 (96%) of the 46 surveyed CTSAs returned 46
responses; two CTSAs submitted two responses, each describing a different set of practices
at separate institutions within their multi-institutional CTSA.* Of the 46 respondents, 26
(57%) were university officials, senior executives, department/core directors, or IRB chairs;
11 (24%) were recruitment or administrative core coordinators or managers; 5 (11%) were
senior faculty; and 4 (9%) were research subject advocates. (For a list of respondents’ self-
reported positions, see Supplemental Digital Appendix 2). All respondents were directly
engaged with their CTSA.
Accrual success
Across the CTSAs, there were no uniform definitions or practices for collecting or analyzing
accrual data and few respondents could report on the outcome of successful accrual (fraction
of studies with complete and timely enrollment). Of the 46 respondents, 37% (17) indicated
specific time periods in response to the questions about elapsed time from sponsored and
nonsponsored protocol approval to first enrolled subject, while most (63%, 29) selected “do
not know.” Although half of the respondents (50%, 23) indicated that their IRB tracked
enrollment, only 9% (4) could report the accrual outcome, that is, the fraction of protocols at
their CTSA for which stated accrual targets were met within 6 months of the target date.
Across a series of questions regarding the tracking of accrual progress, all 46 respondents
indicated that at least one entity tracked enrollment (e.g., the IRB, the cancer center, the
utilization committee, the sponsor), yet, for both sponsored and non-sponsored studies, a
consistent majority (74–78%) reported there were no mechanisms to track the number of
studies failing to accrue within 6 months of target or the number of studies closed for
nonaccrual.
Specific recruitment practices and models for recruitment support
More than half of the 46 respondents (57%, 26) reported their institutions had no
“particularly successful or valuable recruitment or retention practices” to share. Ten
respondents (22%) collectively described 15 practices they deemed valuable, including
metrics for tracking recruitment activities and performance (n = 2 practices), data-based
feasibility assessment practices (n = 3), use of the ResearchMatch8,9 participant registry (n =
3), and recruitment cores providing support services to investigators (n = 7).
*The terms “CTSAs” and “institutions” are used to refer both to the CTSA institutions (i.e., individual entities within multi-entity
CTSAs) and to the CTSAs (i.e., the grant awardees, which can include multiple entities or institutions) represented in the survey
responses.
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When asked to indicate the most commonly utilized approaches to recruitment for studies
that were sponsored, non-sponsored, or conducted at a dedicated center, respondents’ top
three choices, regardless of study type, included the research teams’ own efforts, participant
self-referral from advertisements and Web sites, and referral by a primary caregiver (Table
1). Through both fixed-answer and free-text responses, 57% (26) of the 46 respondents
reported the existence of investigator-managed or departmental-level databases listing
research participants as a resource for recruitment. Twenty-four percent (11) of the
respondents reported hosting an institution-wide registry for which there was an IRB-
approved mechanism to identify and re-contact patients/participants for future research.
Despite common recognition among the respondents that one important component of
successful accrual is feasibility assessment, none reported having an institutional policy to
require or enforce the conduct of routine specific feasibility assessment to justify accrual
targets for either sponsored or non-sponsored studies. However, respondents reported that if
any feasibility information was provided, it was considered by the IRB during protocol
review (30%, 14 of 46) or before finalizing clinical trial contracts (22%, 10). Neither
standards for the conduct of feasibility assessments nor methods for the formal review of
feasibility information at the IRB level were described by respondents. Ten (22%)
respondents indicated investigators were offered some type of feasibility assessments prior
to review at their institutions. A majority of the 46 respondents reported that at their
institutions, accrual targets were chosen, without any basis provided, by sponsors for
sponsored studies (80%, 37) and by investigators for non-sponsored studies (70%, 32).
Fourteen of the 46 respondents (30%) indicated there was an institutional process in place to
help investigators to evaluate feasibility before submitting a protocol to the IRB. Their free-
text descriptions of those feasibility assessments included departmental- or center-level
review (n = 7 respondents); ad hoc review by recruitment core staff or peers (n = 5); and use
of a repository or patient database query to assess participant availability (n = 2).
Institutional resources for recruitment
In response to a question about financial models for providing recruitment services, 26%
(12) of the 46 respondents reported their CTSAs offer free recruitment consultation services
to all investigators and 15% (7) indicated investigators or departments are charged for some
or all recruitment services. However, 61% (28) indicated no resources are offered to
investigators to support recruitment (Figure 1). Fifteen respondents provided free-text
comments describing their institutions’ recruitment services; seven reported assistance
offered with recruitment planning through a core or consultation service, advertising, use of
registries prior to study initiation, and provision of tracking or metrics. Less commonly
offered were help with feasibility assessments or community outreach.
Evaluation of recruitment activities
When asked to give their opinion as to which three aspects of recruitment activities
contributed most to the success of recruitment at their CTSAs, respondents selected the
quality of the recruitment plan overall (52%, 24 of 46), the conduct of a feasibility
assessment (39%, 18), and the nature of the studies being offered (33%, 15) as the most
Kost et al. Page 6






















important factors (Table 2). The ranking of the top two did not vary with the respondent’s
seniority or role. In their free-text comments, respondents did not provide any objective
measures of the effectiveness of their practices.
Institutional policies regarding recruitment and retention
Although 43% (20) of the 46 respondents reported that their IRBs required investigators to
indicate a target date for completion of accrual, none reported justification for the selection
of target dates or feasibility assessment as required at their institution. As noted above, half
of respondents (50%, 23) reported that the IRB tracked whether protocols progressed toward
enrollment. Further, in the event of underaccrual, 63% (29) said that recruitment assistance
in the form of advice, consultation, or increased on-line visibility was offered to
investigators to improve accrual. Most respondents indicated that their institutions had no
formal policy for closing under-accruing sponsored studies (52%, 24) or non-sponsored
studies (71%, 33), although 20% (9) said sponsors themselves closed their poorly accruing
studies and some said the utilization review or contracts office closed sponsored (7%, 3) and
nonsponsored (9%, 4) studies. Eighty-seven percent (40) responded there were no penalties
to investigators for hosting poorly accruing studies.
Regarding current practices in participant retention, 96% (44) of the 46 respondents reported
they had no successful retention practices or outcome data to share. Forty-six percent (21)
reported that retention activities were conducted only by the research team; 17% (8)
described participant newsletters, appreciation events, tokens, reminder calls, and cards as
research team practices to support retention. Thirty-nine percent (18) reported there were no
institutional initiatives to enhance retention. Respondents felt the top contributors to
successful retention at their institutions were convenience factors such as the ease of parking
and waiting time (61%, 28), the quality of the relationship with the coordinator (57%, 26),
the nature of the study (41%, 19), and the use of reminder calls and e-mails (41%, 19)
(Table 3).
Perceived gaps in practice or knowledge
Respondents were asked to indicate up to three practices that they felt would, if made
available at their institutions, enhance recruitment or enhance retention. To improve
recruitment, respondents chose feasibility assessments (49%, 22 of 45), access to participant
registries (44%, 20), and improvements to overall recruitment plans (27%, 12) (Table 4).
These were the top three selections regardless of the participant’s role or seniority. Thirty-
two respondents also provided free-text comments suggesting ways to improve retention of
participants; these included sharing research results and study progress with participants
(31%, 10 of 32), assuring adequate or free parking (28%, 9), attending to the quality of the
relationships with research team members (22%, 7), appointment reminders (13%, 4), and
the development of researcher-directed retention training and protocol-specific retention
plans (6%, 2).
When asked what recruitment models, practices, or metrics they most wanted to learn more
about, 20 respondents provided free-text comments asking for metrics of successful
practices (55%, 11), details of how to conduct specific recruitment practices (50%, 10),
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models for creating a recruitment core (40%, 8), means to tailor recruitment to specific
studies or populations (35%, 7), information on setting up registries or databases (15%, 3),
and means to achieve outreach through social media networks (15%, 3). Regarding the
retention models, practices, or metrics they most wanted to learn about, 17 respondents
commented, asking for retention metrics (35%, 6), successful organizational models and
tools for retention (35%, 6), methods of predicting or measuring retention (18%, 3), and
information on tailoring retention methods to study characteristics (12%, 2).
Discussion
We report here the results of a 2010 national survey of CTSAs about practices relating to
clinical research recruitment and accrual. Major aspects of recruitment practices were
assessed: accrual outcomes; utilization and perceived success of common recruitment and
retention practices; institutional resources and infrastructure to support recruitment;
evaluation methods for recruitment practices; relevant institutional policy and expectations
regarding study feasibility and accrual; and perceived gaps in knowledge or practice.
All 46 respondents indicated that the IRBs at the 44 CTSAs they represented collected
ongoing enrollment data and a majority indicated an enrollment target date was required.
However, few reported their CTSAs required any justification for enrollment targets, and
only 13% (6) reported their CTSAs had the ability to track accrual as an outcome of
successful recruitment, that is, whether a study achieved timely and complete accrual. Few
respondents could report how many studies had no accrual or were closed for poor accrual.
For many of the questions, many respondents indicated their institutions did not track the
data queried. More than 50% of the respondents said there were no policies in place to
manage underaccruing studies and 87% said there were no administrative actions (penalties)
consistently taken to address or limit underenrolling studies. Although 50% of the
respondents reported that underenrolling studies were referred for some type of recruitment
assistance or advice, few provided any measures of the effectiveness of any recruitment
assistance or practices conducted at their institution.
These data suggest that most CTSAs have not created the basic framework for the
systematic assessment of accrual. Federal regulations require that investigators report and
IRBs monitor ongoing enrollment data at continuing review, yet one can infer from our
results that CTSAs have not accessed or leveraged these data. Enrollment data appear to
exist in silos, and in the absence of standard definitions or milestones. Challenges to data
analysis, such as variation in the operational definition of when enrollment starts or inflation
of enrollment targets to accommodate screen failures and attrition, may be present. These
barriers to the use of accrual data could be lowered by the development of consensus
definitions and recommended best practices for projecting and tracking accrual.
The ability to formulate and execute a successful plan for study accrual depends on having
multiple integrated resources in place. Recently, following their report of the institutional
impact of underenrollment,3 Kitterman et al10 reported their two-year experience with an
institutional program designed to heighten awareness of investigators’ self-identified
barriers to accrual. They reported wide variance across departments in improvement or
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worsening of accrual rates without significant net change in the overall rate of low enrolling
studies.
Key elements of provision of integrated support include leadership and policies to set and
reinforce expectations of successful accrual, resources and expertise to guide and support the
planning and conduct of recruitment efforts, and a commitment to evaluate the effectiveness
of recruitment efforts. Timely accrual is the most appropriate primary outcome measure. To
date, many CTSAs have enhanced select infrastructure and support for investigators in the
form of laboratory cores, standardization and centralization of training, and provision of
protocol development and research coordination services.11,12 Consortium-wide efforts have
focused on means to streamline study approval.13 Given the critical role of successful
recruitment in all clinical research protocols, the RR taskforce makes the following
recommendations to the CTSA consortium to achieve the goal of improving participant
accrual:
Recommendation 1: Institutional leadership must make a clear statement that timely and
effective recruitment is an expectation of the clinical research enterprise. Policies should
be developed to support that expectation
There must be a major change in culture at academic institutions regarding the approach to
clinical research in order to effect the needed change in productivity. Policies should address
approaching study selection rationally, setting accrual targets based on data, and requiring
accountability for accrual performance. Many CTSA leaders may be well positioned to
facilitate addressing these challenges at the institutional level.
Accrual performance outcomes are the key benchmark for the delivery of recruitment
services, yet at many institutions, accrual targets are not consistently based on rational or
systematic feasibility assessments. For both sponsored and investigator-initiated studies, a
robust assessment of feasibility takes into account multiple factors affecting accrual, such as
the availability of and appeal the study holds for the target population, and operational
factors, such as competing priorities and protocols, available personnel and resources, past
experience in similar circumstances, and the opportunity costs of conducting the study.
Overestimation of the anticipated accrual rate results in wasted allocation of resources and
effort, whereas underestimation may leave a study team underresourced to meet the
demands of conducting the study.
However, to make accrual outcome assessment a meaningful practice consortium-wide,
institutions must share common definitions and standards for tracking and analyzing accrual
data. Recently the CTSA Evaluation Committee engaged CTSA leadership regarding
outcome metrics, drafted working definitions, and initiated a metrics pilot project to assess
the feasibility of capturing accrual data across the consortium.14 It will be important to
couple this top-down approach with engagement of the recruitment professionals already on
the front lines as they have a broad fund of knowledge relevant to this agenda.
The value of different approaches to feasibility analysis should also be based on assessments
of the effectiveness of those approaches. Many survey respondents selected feasibility
assessments as among the practices of greatest value to current and future recruitment
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support, and they asked for best practices and metrics. Despite the widespread embrace of
feasibility assessments as key to successful recruitment, there are no consensus best
practices, and there is a lack of institutional requirements for rational justification of
enrollment targets. Interestingly, in a study of 14 cancer centers among which the study
zero-accrual rate exceeded 50%, the implementation of a requirement for a simple
preliminary feasibility assessment--specifically, to demonstrate the availability of a minimal
set of eligible patients--virtually eliminated the incidence of non-enrolling studies by merely
focusing attention and intention on the issue.15 Some tools are already at hand within the
consortium to enable broader application and testing of feasibility approaches. Several
informatics-rich institutional models for assessing aspects of feasibility have been published
recently.16–18 The nationwide ResearchMatch database is but one example of a volunteer
registry that can be formally queried to assess participant availability.8 A fully
comprehensive feasibility assessment would utilize both information gleaned from
informatics queries of participant registries or patient databases and recruitment expertise to
assist investigators to minimize protocol burdens, maximize benefits and incentives, reduce
protocol complexity and preserve scientific goals and integrity.
Recommendation 2: Institutions should provide investigators access to recruitment
expertise through consultation and/or core services to support effective prospective
recruitment planning and conduct
In a 2010 report, the Institute of Medicine identified structured, consistent support for
investigators to carry out translational research, including the provision of recruitment
services, as a critical component in transforming clinical research.1 In its 2013 report on the
CTSAs, the Institute of Medicine again noted that low or slow accrual presents a significant
barrier to the conduct of translational research.2 Successful accrual often requires more
effort specifically focused on recruitment than can be spared by a busy research coordinator
with a broad scope of duties.12 Further, in the modern era, recruitment implementation
requires expertise in marketing, social networking, registry management, advertising
graphics and placement, branding, internet presence, community engagement and outreach,
call management, customer service, and other special services. Planning for successful
recruitment requires systematic formal assessment early, during the protocol development
process, of issues such as the availability of the target patient population15,18; the presence
of competing protocols across the institution and region; the operational feasibility of the
study design in terms of staffing, space, intensity, burdens, and incentives; the budget for
recruitment marketing; call management; and the availability of the research team to
conduct study visits.4,6 The coordination of these data streams and activities is often beyond
the scope of the investigator, thus, the provision of recruitment expertise by the institution is
key.
Finally, it is critical to recognize the role of prospective planning in ensuring that
recruitment support costs are anticipated and well-budgeted through effective institutional
mechanisms to allow utilization of available recruitment services, with economies of scale
where possible. At many institutions, the CTSA may be the logical home for centralized
professional recruitment consultation and services. The review criteria for the most recent
CTSA funding announcement19 ask whether proposed resources and services address
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“critical barriers for translational researchers and research teams locally.” Recent Institute of
Medicine recommendations also call for accountability to common metrics for research
performance outcomes.2 Concrete steps to systematically eliminate barriers to effective
recruitment and accrual by providing recruitment expertise would be responsive to these
recommendations.
Recommendation 3: Robust ongoing evaluation of recruitment and accrual activities
should be an essential part of institutional expectations. Evaluation efforts should be
supported by appropriate integrated data infrastructure and analysis resources to assess
and improve performance outcomes
In our survey, only one-third of respondents indicated their institution offered some form of
recruitment services for investigators (e.g., consultation, planning, feasibility assessments,
management registries, advertising, call management, tracking and analysis of outcome
metrics). Since the fielding of the survey, the prevalence of recruitment cores and participant
and patient registries has increased steadily although there is no centralized listing to track
their growth. Two years after the survey, 7 CTSAs presented participant registries at a
national meeting,20 and in late March 2014, 87 institutions affiliated with 52 CTSAs were
listed as participating in the national ResearchMatch registry.21 In 2014, one of the authors
(R.K.) reviewed the public websites of the 62 funded CTSAs, where the descriptions of the
recruitment services offered to investigators to enhance participant recruitment ranged from
isolated access to ResearchMatch to local and disease-specific patient registries, informatics-
assisted feasibility searches of patient databases, recruitment tool/templates, and expert
consultation or services.
Despite this encouraging recent proliferation of recruitment cores and services, it is
unknown whether institutions have used their new platforms to study and optimize their
practices as there are few published data demonstrating the value and effectiveness of these
services. Notably, ResearchMatch provides partnering institutions with private dashboards
illustrating the effectiveness of their own ResearchMatch recruitment activities along the
enrollment continuum8; the efficiency of ResearchMatch overall has been reported.9
Contemporaneously, there have been creative approaches to incorporate research subject
advocacy and community outreach into recruitment strategies, and dedicated recruitment
portals and registries have been promoted to educate the public about research
opportunities.9,22 In addition, cross-consortium efforts have been made to develop validated
instruments to understand participant motivations.23,24 However, demonstrations of the
utility and effectiveness of these models at enhancing recruitment outcomes are lacking. RR
taskforce members (including RK, SM-B, CR, HK, CDH, AD, RH) report that their
recruitment cores typically capture detailed information about their callers and activities, but
lack either necessary infrastructure or collaboration from research teams to routinely
reconcile referral data with enrollment outcomes. We are unaware of any publications that
evaluate the effectiveness of recruitment core models, yet effectiveness data are crucial
when attempting to justify funding requests for support of recruitment activities in grants or
within institutions, or when allocating resources internally. The support of leadership across
multiple domains is required for effective service models, practices, and activities to be
evaluated and disseminated.
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Similarly, evidence is needed to support survey respondents’ message that participant
registries are a valuable resource for accrual. As noted above, there has been a recent surge
in the development of participant registries at CTSAs, which have reported a wide range of
experiences in realizing the full potential of such registries.20 Some registries are configured
to allow potential participants to search for protocols of interest and request additional
information,25 whereas others are configured to match eligible participants to protocols in a
blinded fashion based on participant profiles.8,9 Centralized research participant registries
provide a potential platform for optimizing approaches to recruitment, understanding the
relative merits of different approaches for different target populations, and for linking
recruitment practices to accrual outcomes. The most broadly available registry is the
national ResearchMatch registry with enrollment of 53,975 as of March 23, 2014.8 Data
shared with us by one co-author (R.H.) indicate that, although some enrollments are
underreported, of the 12,761 volunteers contacted by researchers at that author’s university
as a result of being “matched” within ResearchMatch, 4,289 (34%) were confirmed to have
enrolled in studies at the CTSA.26 To date, however, few other registries have published
data on their effectiveness.
The lack of evaluation of various recruitment activities and of overall accrual success is
almost universal even though IRB procedures uniformly require a statement of the
enrollment target; this and the routine collection of accrual data as part of continuing review
are required by federal guidance.27 Similarly, standard financial practices in contracting
offices require capture of data on the returns and losses accruing from clinical trials. The
paucity of outcome data offered by survey respondents highlights how opportunities to
leverage data across functions and departments are missed in the absence of intentional
efforts to bridge departmental silos. The opportunity exists at every CTSA to assess the
effectiveness of recruitment practices by analyzing existing data sources, across departments
and functions, to routinely track study accrual and to respond as needed to improve accrual.
Such integration requires recognition at the leadership level of the need to provide resources
for common data access infrastructure and processes as well as policies to require such
evaluations. Coordination and partnerships between CTSA core directors, IRB officials, and
contract and clinical trial staff are critical to the development and implementation of
effective recruitment practices, including those related to feasibility assessments. The
benefit of such a systematic approach will be the ability to provide recruitment resources in
a manner demonstrated to be cost-effective.
Limitations
There were several limitations to the survey. Because most recruitment activities are
delegated to research teams, our senior-level respondents, even if well informed, may have
been limited in their ability to represent the full spectrum of recruitment and retention
practices and issues across their CTSAs. In anticipation of this possibility, at the time of the
survey fielding, we also offered hosting and analysis of a second, investigator-level version
of the survey by which CTSAs could survey their own investigators to ascertain the breadth
of practices specific to their institutions. Only two CTSAs used the local survey; their data
were returned to them and results have not been reported. A second limitation is that the
survey did not include any ascertainment of outreach directed to participants or
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communities. Emerging data support the important role of participant-centered values in
study recruitment and retention.23,24,28 However, the focus of the current survey was to
obtain broad observations of recruitment practices, support, and evaluation efforts at
CTSAs. Comprehensive attention to specific practices and tests of their effectiveness in
multiple contexts are logical next steps in what must be a multi-step process for improving
recruitment at CTSAs.
Conclusions
The 46 respondents from 44 CTSAs who completed the RR taskforce survey reported that
approximately one-third of CTSAs offer some recruitment-related support to investigators
such as consultations, management of participant registries, conduct of feasibility
assessments, and provision of expertise, tools, and services to execute, track, and document
effective recruitment. Few institutions to date have been able to evaluate recruitment success
or the effectiveness and value of recruitment services due to a lack of policy, definitions, and
standard evaluation practices. The financial accountability to funding agencies and ethical
accountability to participants demand that recruitment and accrual be conducted robustly,
systematically, and successfully, leveraging the talents and infrastructure of the CTSAs. In
alignment with the CTSA funding mechanism, CTSA Integrated Home Leadership is
expected to “evaluate the effectiveness of their plan for ensuring high quality and efficient
human subjects research, including the appropriateness of study design, recruitment,
feasibility and timely closure of futile studies.”12 Based on the results of this survey, the RR
taskforce recommends that CTSA leaders establish formal expectations for timely
recruitment, support infrastructure for delivery of recruitment services and for data capture,
and foster a culture of data-driven decision-making. Piloting expert recruitment consultation
services, collecting performance data systematically, analyzing data to establish
benchmarks, improving and evaluating the cost-effectiveness of practices, and formalizing
accountability will hasten the identification of the most valuable and effective recruitment
models and practices for dissemination.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Institutional recruitment resources to assist investigators in accrual of clinical research
studies: Frequency and financial model, results of a Clinical and Translational Award
(CTSA) consortium-wide survey, 2010. The survey question stated: “If recruitment services
are provided to investigators from a center or central service, what is the financial model?”
The 46 respondents representing 44 CTSAs selected one or more options from among the
choices listed along the vertical axis. The figure shows the frequency of the utilization of
different service models and the general handling of the cost of the services, including
instances where services were free or no services were provided.
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Table 1
Recruitment Methods Reported as Most Commonly Used at CTSAs, by Type of Clinical Protocol, Results of a
2010 CTSA Consortium-Wide Survey (N = 46 Respondents From 44 CTSAs)a
Participant recruitment method
No. (%) of respondents reporting method used for
Sponsored studiesb Non-sponsored studiesc
Studies at a dedicated
center (e.g., vaccine or
cancer center)d
By individual research teams (PI and coordinator/nurses) 40 (87) 42 (91) 36 (78)
Self-referral via Web sites and advertisements 35 (76) 33 (72) 29 (63)
Referral by a primary caregiver 29 (63) 30 (65) 30 (65)
Mixed model: by individual teams, and by central resources 11 (24) 7 (15) 12 (26)
Referral through a volunteer registry 8 (17) 11 (24) 7 (15)
By a central recruitment office/team at the center 1 (2) 1 (2) 6 (13)
By a subcontract to an outside recruiting agency 1 (2) 1 (2) 0
Don’t know 1 (2) 1 (2) 0
Abbreviations: CTSA indicates Clinical and Translational Science Award; CTSAs, CTSA sites.
a
Respondents were asked to indicate the three types of recruitment most commonly utilized for the specific study types at their institution; there are
no common standards for aggregating this data. They were encouraged to access local content experts and/or host the available institution-local
version of the survey to obtain accurate data.
b
Defined in the survey instructions as follows: “‘Sponsored’ protocols are studies for which the main decision-making authority lies with industry/
pharmaceutical, or other outside collaborators and not with the Principal Investigator.”
c
Defined in the survey instructions as follows: “‘Non-sponsored’ protocols are studies for which the main decision-making authority is not held by
an outside sponsor and is usually held by the Principal Investigator.”
d
No additional definition was provided for this study type.
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Table 2
Factors Contributing to Successful Clinical Study Recruitment, Results of a 2010 CTSA Consortium-Wide
Survey (N = 46 Respondents From 44 CTSAs)
Factors affecting recruitment success
No. (%) of respondents selecting the factor as most
importanta
Quality of recruitment plan overall 24 (52)
Feasibility of recruitment assessment performed before starting recruitment 18 (39)
The nature of the studies (e.g., trials offering novel treatments) 15 (33)
Relationship established with coordinator 13 (28)
Relationship established with investigator 10 (22)
Financial compensation for participants 10 (22)
Recruitment of prior volunteers through coordinators 9 (20)
Adequate budget 9 (20)
Referral of participants by their personal physicians 8 (17)
Nature/quality of first interaction (telephone pre-screen, scheduling, etc.) 5 (11)
Recruitment of willing volunteers from a participant registry 5 (11)
Through referral/collaboration with private practitioners 4 (9)
Quality of informed consent discussion with investigator 2 (4)
Quality of informed consent discussion with coordinator 1 (2)
Quality of advertising 1 (2)
Quality of recruitment services from support center 0
Other (please specify)b 4 (9)
Abbreviations: CTSA indicates Clinical and Translational Science Award; CTSAs, CTSA sites.
a
Respondents were asked “What do you believe are the three most important elements of successful recruitment at your CTSA?,” operationally
defined as timely accrual. There are currently no common standards or definitions for evaluating or aggregating this information. Respondents
relied on local infrastructure, reporting, and expertise to compile responses.
b
The four respondents who selected this response option provided text descriptions of elements of successful recruitment plans: “having dedicated
recruitment experts support the research team”; “a research-informed public”; “having access to target populations”; “the participant’s relationship
with the research team.”
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Table 3
Factors Contributing to Successful Clinical Study Retention, Results of a 2010 CTSA Consortium-Wide
Survey (N = 46 Respondents From 44 CTSAs)
Factors affecting successful retention
No. (%) of respondents
selecting the factor as most
importanta
Comfort/convenience factors: distance of commute to research site, availability of parking, ease of finding
research clinic, waiting time
28 (61)
Quality of the relationship established with the coordinator 26 (57)
The nature of the study itself (e.g. trials offering novel treatments) 19 (41)
Reminder calls/e-mails before return visits 19 (41)
Quality of the relationship established with investigator 10 (22)
Financial compensation for participants 8 (17)
Participant’s prior experience in research studies 7 (15)
Involvement and buy-in from the referring physician 7 (15)
Participant appreciation efforts (gifts, gatherings, acknowledgements) 5 (11)
No-placebo protocols 2 (4)
Retention prediction assessment 2 (4)
Referral of participants from personal physicians 1 (2)
Other (please specify)b 4 (9)
Abbreviations: CTSA indicates Clinical and Translational Science Award; CTSAs, CTSA sites.
a
Respondents were asked, “What are the three most important elements of successful retention [of study participants] at your CTSA?” There are no
definitions or consensus practices for assessing retention practices. Respondents relied on local infrastructure, reporting, and expertise to compile
responses.
b
The four respondents who selected this response option provided text descriptions of successful retention practices: “the quality of the relationship
with the research team and reminder calls”; “the design of the protocol itself”; “compensation”; “the study purpose.”
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Table 4
Recruitment Planning Practices Wish List, Results of a 2010 CTSA Consortium-Wide Survey (N = 45
Respondents From 44 CTSAs)
Recruitment service or factor No. (%) of respondents selecting service or factora
Feasibility of recruitment assessment performed before starting recruitment 22 (49)
Recruitment of willing volunteers from a participant registry 20 (44)
Quality of recruitment plan overall 18 (40)
Adequate budget 12 (27)
Quality of recruitment services from support center 10 (22)
Referral of participants from personal physicians 6 (13)
Nature/quality of first interaction (telephone pre-screen, scheduling, etc.) 6 (13)
Quality of advertising 5 (11)
Recruitment of prior volunteers through coordinators 5 (11)
Relationship established with investigator 4 (9)
The nature of the studies (e.g. trials offering novel treatments) 2 (4)
Relationship established with coordinator 2 (4)
Financial compensation for participants 2 (4)
Quality of informed consent discussion with investigator 1 (2)
Quality of informed consent discussion with coordinator 1 (2)
Other (please specify)b 10 (22)
Abbreviations: CTSA indicates Clinical and Translational Science Award; CTSAs, CTSA sites.
a
Respondents were asked to render an informed opinion from the list of services and factors above to answer the following question: “Select up to
three additional activities that you think would enhance recruitment at your center if they could be provided.”
b
Among the respondents’ comments, additional themes raised included training and retention of research coordinators, incorporating a participant-
centered perspective in the design of the research study, better engagement of clinicians/practitioners/providers to refer patients to research, and
helping research teams understand the impact of their interactions on participants.
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